Medical News

---

• Comorbid anxiety problematic for adolescents with bipolar disorder
• Comorbid anxiety problematic for adolescents with bipolar disorder
• Metacognitive training complements antipsychotic therapy
• Weight loss reduces pediatric exercise-induced bronchoconstriction
• Metacognitive training complements antipsychotic therapy
• Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy
• DNA methylation signature marks recurrence in early stage lung cancer
• FDG-PET parameter predicts locally advanced lung cancer survival
• Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy
• DNA methylation signature marks recurrence in early stage lung cancer
• FDG-PET parameter predicts locally advanced lung cancer survival

Comorbid anxiety problematic for adolescents with bipolar disorder Posted: 31 Oct 2013 05:00 PM PDT Anxiety disorders are common in children and adolescents with bipolar disorder and adversely affect their outcomes, suggest study findings.

Comorbid anxiety problematic for adolescents with bipolar disorder Posted: 31 Oct 2013 05:00 PM PDT Anxiety disorders are common in children and adolescents with bipolar disorder and adversely affect their outcomes, suggest study findings.

Metacognitive training complements antipsychotic therapy Posted: 31 Oct 2013 05:00 PM PDT Metacognitive training may benefit patients with schizophrenia who only partially respond to antipsychotic treatment, study findings show.

Weight loss reduces pediatric exercise-induced bronchoconstriction Posted: 31 Oct 2013 05:00 PM PDT A study has found that weight loss in overweight and obese children with exercise-induced bronchoconstriction leads to a significant reduction in symptom severity and improved quality of life.

Metacognitive training complements antipsychotic therapy Posted: 31 Oct 2013 05:00 PM PDT Metacognitive training may benefit patients with schizophrenia who only partially respond to antipsychotic treatment, study findings show.

Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy Posted: 30 Oct 2013 05:00 PM PDT Two targeted anticancer drugs used together after first-line chemotherapy for advanced stage non-small-cell lung cancer improve progression-free survival, the results of a large, prospective study show.

DNA methylation signature marks recurrence in early stage lung cancer Posted: 30 Oct 2013 05:00 PM PDT An international research team has identified a DNA methylation signature that identifies patients with stage I non-small-cell lung cancer who are at high risk for relapse.

FDG-PET parameter predicts locally advanced lung cancer survival Posted: 30 Oct 2013 05:00 PM PDT High post-treatment concentrations of a radioactive imaging marker are predictive of worse overall survival from inoperable, locally advanced non-small-cell lung cancer, prospective study findings suggest.

Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy Posted: 30 Oct 2013 05:00 PM PDT Two targeted anticancer drugs used together after first-line chemotherapy for advanced stage non-small-cell lung cancer improve progression-free survival, the results of a large, prospective study show.

DNA methylation signature marks recurrence in early stage lung cancer Posted: 30 Oct 2013 05:00 PM PDT An international research team has identified a DNA methylation signature that identifies patients with stage I non-small-cell lung cancer who are at high risk for relapse.

FDG-PET parameter predicts locally advanced lung cancer survival Posted: 30 Oct 2013 05:00 PM PDT High post-treatment concentrations of a radioactive imaging marker are predictive of worse overall survival from inoperable, locally advanced non-small-cell lung cancer, prospective study findings suggest.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610